trial · primary record
ECP-DL treated mononuclear cell infusion
Kidney Transplant Failure and Rejection
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 24 |
| Primary completion | 2029-12-25 |
| Primary endpoint | Incidence of Adverse Events Following Escalating Doses of ECP-DL Cells |
| Registry ID | NCT07083830 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:32.426Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07083830
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.